Switch to a High-Intensity Statin or Add Ezetimibe
If your LDL remains elevated on pravastatin 80 mg, you should switch to a high-intensity statin (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) or add ezetimibe 10 mg to your current pravastatin regimen. 1
Why Pravastatin 80 mg May Be Insufficient
Pravastatin 80 mg is classified as only moderate-intensity statin therapy, achieving approximately 30-49% LDL reduction 1. The FDA label explicitly states that "for patients that require a high-intensity statin or are unable to achieve their LDL-C goal receiving pravastatin sodium tablets 80 mg daily, prescribe alternative LDL-C-lowering treatment" 2. This is a critical point: you've reached the maximum dose of pravastatin, but it's still not a high-intensity regimen.
Algorithmic Approach to Your Next Step
Step 1: Determine Your Cardiovascular Risk Category
- Very high risk (prior MI, stroke, ACS, or multiple high-risk conditions): Target LDL <70 mg/dL (1.8 mmol/L) 3
- High risk (diabetes, strong family history, multiple risk factors): Target varies but generally <100 mg/dL
- Moderate risk: Less aggressive targets apply
Step 2: Choose Your Strategy Based on Risk
Option A: Switch to High-Intensity Statin (Preferred for Most Patients)
- Atorvastatin 40-80 mg achieves ≥50% LDL reduction 1
- Rosuvastatin 20-40 mg achieves ≥50% LDL reduction 1
- These are significantly more potent than pravastatin 80 mg 4, 5
- Clinical trials show atorvastatin 80 mg reduces LDL to approximately 1.60 mmol/L (62 mg/dL) compared to pravastatin 40 mg achieving only 2.46 mmol/L (95 mg/dL) 4
Option B: Add Ezetimibe 10 mg to Current Pravastatin
- Reasonable if you tolerate pravastatin well and prefer not to switch
- Ezetimibe adds approximately 15-20% additional LDL reduction 3
- For very high-risk patients: Add ezetimibe when LDL remains ≥70 mg/dL on maximally tolerated statin 3
- European guidelines strongly recommend this combination approach 3
Step 3: Reserve PCSK9 Inhibitors for Refractory Cases
- Only consider if LDL remains ≥100 mg/dL (2.6 mmol/L) on both maximum statin AND ezetimibe 3
- These are expensive and reserved for very high-risk patients who fail combination therapy
Why Switching Statins Works Better
The dose-response relationship matters here. Pravastatin has the weakest dose-response slope among statins—each doubling of dose only reduces LDL by 3.4% 6. In contrast, atorvastatin and rosuvastatin are far more potent per milligram 5, 7. Research directly comparing these agents shows atorvastatin 80 mg produces greater LDL reduction AND better clinical outcomes (fewer MIs, revascularizations) than pravastatin 40 mg 4.
Common Pitfalls to Avoid
- Don't stay on inadequate therapy: Pravastatin 80 mg is the ceiling, and it's only moderate-intensity 1, 2
- Don't add ezetimibe without first considering a statin switch: High-intensity statins alone may achieve your goal more cost-effectively
- Don't forget to recheck lipids: Assess LDL as early as 4 weeks after any change 2
- Watch for drug interactions: If switching to atorvastatin or rosuvastatin, review medications that increase myopathy risk (cyclosporine, clarithromycin, gemfibrozil) 1, 2
Practical Recommendation
For most patients, switch to atorvastatin 40-80 mg daily. This single change will likely achieve your LDL goal without adding another medication. If you're at very high cardiovascular risk and still don't reach target on atorvastatin 80 mg, then add ezetimibe 10 mg 3. This stepwise intensification approach is supported by the 2022 BMJ guidelines and multiple international societies 3.
The 2019 ACC/AHA guidelines make clear that achieving adequate LDL reduction directly correlates with cardiovascular event reduction—approximately 1% risk reduction per 1% LDL lowering 1. You need a more potent regimen, and the evidence strongly supports switching to high-intensity statin therapy first.